Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
O

Optima Health PLC
F:J3N

Watchlist Manager
Optima Health PLC
F:J3N
Watchlist
Price: 2.88 EUR Market Closed
Market Cap: €255.7m
Write Note Create Alert Ask AI

Wall St Price Targets

J3N Price Targets Summary
Optima Health PLC

Wall Street analysts forecast J3N stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for J3N is 2.42 EUR with a low forecast of 2.33 EUR and a high forecast of 2.62 EUR.

J3N Lowest Forecast
Wall Street Target
€2.33
-19% Downside
J3N Average Forecast
Wall Street Target
€2.42
-16% Downside
J3N Highest Forecast
Wall Street Target
€2.62
-9% Downside
Lowest Forecast
Price Target
2.33 EUR
19% Downside
Average Forecast
Price Target
2.42 EUR
16% Downside
Highest Forecast
Price Target
2.62 EUR
9% Downside
Optima Health PLC Competitors:
Price Targets

Revenue
Forecast

-5% / Year
Past Growth
31% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-5% / Year
Past Growth
31% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 3 years is 31%.

What are analyst estimates?

Gross Profit
Forecast

-5% / Year
Past Growth
11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-5% / Year
Past Growth
11% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Gross Profit has been -5%. The projected CAGR for the next 3 years is 11%.

What are analyst estimates?

Operating Income
Forecast

-4% / Year
Past Growth
21% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-4% / Year
Past Growth
21% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Operating Income has been -4%. The projected CAGR for the next 8 years is 21%.

What are analyst estimates?

Pre-Tax Income
Forecast

90% / Year
Past Growth
87% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
90% / Year
Past Growth
87% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Pre-Tax Income has been 90%. The projected CAGR for the next 3 years is 87%.

What are analyst estimates?

Net Income
Forecast

2% / Year
Past Growth
128% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
2% / Year
Past Growth
128% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 3 years is 128%.

What are analyst estimates?

Continue J3N Research

Summary
J3N intrinsic value, competitors valuation, and company profile.
DCF Valuation
J3N stock valuation using Discount Cash Flow valuation method.
Relative Valuation
J3N stock valuation using valuation multiples.
Wall St Estimates
J3N price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
J3N stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Optima Health PLC listings:
LSE • GBX
OPT
 OTC • USD
OHLTF
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is J3N's stock price target?
Price Target
2.42 EUR

According to Wall Street analysts, the average 1-year price target for J3N is 2.42 EUR with a low forecast of 2.33 EUR and a high forecast of 2.62 EUR.

What is the Revenue forecast for Optima Health PLC?
Projected CAGR
31%

Over the last 2 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 3 years is 31%.

What is the Gross Profit forecast for Optima Health PLC?
Projected CAGR
11%

Over the last 2 years, the compound annual growth rate for Gross Profit has been -5%. The projected CAGR for the next 3 years is 11%.

What is the Operating Income forecast for Optima Health PLC?
Projected CAGR
21%

Over the last 2 years, the compound annual growth rate for Operating Income has been -4%. The projected CAGR for the next 8 years is 21%.

What is the Pre-Tax Income forecast for Optima Health PLC?
Projected CAGR
87%

Over the last 2 years, the compound annual growth rate for Pre-Tax Income has been 90%. The projected CAGR for the next 3 years is 87%.

What is the Net Income forecast for Optima Health PLC?
Projected CAGR
128%

Over the last 2 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 3 years is 128%.

Back to Top
ALPHA SPREAD
Follow us
Join 353,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett